-
Mashup Score: 16Right ventricular assessment of the adolescent footballer’s heart - Echo Research & Practice - 2 month(s) ago
Introduction Athletic training can result in electrical and structural changes of the right ventricle that may mimic phenotypical features of arrhythmogenic right ventricular cardiomyopathy (ARVC), such as T-wave inversion and right heart dilatation. An erroneous interpretation may have consequences ranging from false reassurance in an athlete vulnerable to cardiac arrhythmias, to unnecessary sports restriction in a healthy individual. The primary aim of this study was to define normal RV dimension reference ranges for academy adolescent footballers of different ethnicities. Secondary aims include analysis of potential overlap between this adolescent group with ARVC criteria and comparison with normal adult ranges. Results Electrocardiographic (ECG) and echocardiographic data of 1087 academy male footballers aged between 13 and 18 years old (mean age 16.0 ± 0.5 years), attending mandatory cardiac screening were analysed. Ethnicity was categorised as white (n = 826), black (African/Cari
Source: echo.biomedcentral.comCategories: General Medicine News, Cardiologists1Tweet
-
Mashup Score: 6Echocardiographic assessment of aortic regurgitation: a narrative review - Echo Research & Practice - 3 month(s) ago
Aortic regurgitation (AR) is the third most frequently encountered valve lesion and may be caused by abnormalities of the valve cusps or the aorta. Echocardiography is instrumental in the assessment of AR as it enables the delineation of valvular morphology, the mechanism of the lesion and the grading of severity. Severe AR has a major impact on the myocardium and carries a significant risk of morbidity and mortality if left untreated. Established and novel echocardiographic methods, such as global longitudinal strain and three-dimensional echocardiography, allow an estimation of this risk and provide invaluable information for patient management and prognosis. This narrative review summarises the epidemiology of AR, reviews current practices and recommendations with regards to the echocardiographic assessment of AR and outlines novel echocardiographic tools that may prove beneficial in patient assessment and management.
Source: echo.biomedcentral.comCategories: General Medicine News, Cardiologists1Tweet-
RT @EchoResPract: 🚨NEW ARTICLE🚨 Echocardiographic assessment of aortic regurgitation: A narrative review: https://t.co/Es0AC8Vgbl @justvi…
-
-
Mashup Score: 2Validation of administrative claims to identify ultrasound enhancing agent use - Echo Research & Practice - 3 month(s) ago
Background Ultrasound enhancing agents (UEAs) are an invaluable adjunct to stress and transthoracic echocardiography (STE) to improve left ventricular visualization. Despite multiple single center studies evaluating UEA use, investigation into the rates, sources of variation, and outcomes of UEA use on a national level in the United States (US) has been limited by lack of validation of UEA codes for claims analyses. Methods We conducted a retrospective cross-sectional study, 2019–2022, using linked multicenter electronic medical record (EMR) data from > 30 health systems linked to all-payor claims data representing > 90% of the US population. Individuals receiving STE in both EMR and claims data on the same day during the study window were included. UEA receipt as identified by presence of a Current Procedural Terminology (CPT) or National Drug Code (NDC) for UEA use within 1-day of the index STE event. We evaluated the performance of claims to identify UEA use, using EMR data as the g
Source: echo.biomedcentral.comCategories: General Medicine News, CardiologistsTweet-
RT @EchoResPract: 🚨NEW ARTICLE🚨 Validation of administrative claims to identify ultrasound enhancing agent use: https://t.co/MARLQD1AeF @…
-
-
Mashup Score: 2Validation of administrative claims to identify ultrasound enhancing agent use - Echo Research & Practice - 3 month(s) ago
Background Ultrasound enhancing agents (UEAs) are an invaluable adjunct to stress and transthoracic echocardiography (STE) to improve left ventricular visualization. Despite multiple single center studies evaluating UEA use, investigation into the rates, sources of variation, and outcomes of UEA use on a national level in the United States (US) has been limited by lack of validation of UEA codes for claims analyses. Methods We conducted a retrospective cross-sectional study, 2019–2022, using linked multicenter electronic medical record (EMR) data from > 30 health systems linked to all-payor claims data representing > 90% of the US population. Individuals receiving STE in both EMR and claims data on the same day during the study window were included. UEA receipt as identified by presence of a Current Procedural Terminology (CPT) or National Drug Code (NDC) for UEA use within 1-day of the index STE event. We evaluated the performance of claims to identify UEA use, using EMR data as the g
Source: echo.biomedcentral.comCategories: General Medicine News, CardiologistsTweet-
RT @EchoResPract: 🚨NEW ARTICLE🚨 Validation of administrative claims to identify ultrasound enhancing agent use: https://t.co/MARLQD1AeF @…
-
-
Mashup Score: 2Validation of administrative claims to identify ultrasound enhancing agent use - Echo Research & Practice - 3 month(s) ago
Background Ultrasound enhancing agents (UEAs) are an invaluable adjunct to stress and transthoracic echocardiography (STE) to improve left ventricular visualization. Despite multiple single center studies evaluating UEA use, investigation into the rates, sources of variation, and outcomes of UEA use on a national level in the United States (US) has been limited by lack of validation of UEA codes for claims analyses. Methods We conducted a retrospective cross-sectional study, 2019–2022, using linked multicenter electronic medical record (EMR) data from > 30 health systems linked to all-payor claims data representing > 90% of the US population. Individuals receiving STE in both EMR and claims data on the same day during the study window were included. UEA receipt as identified by presence of a Current Procedural Terminology (CPT) or National Drug Code (NDC) for UEA use within 1-day of the index STE event. We evaluated the performance of claims to identify UEA use, using EMR data as the g
Source: echo.biomedcentral.comCategories: General Medicine News, CardiologistsTweet-
RT @EchoResPract: 🚨NEW ARTICLE🚨 Validation of administrative claims to identify ultrasound enhancing agent use: https://t.co/MARLQD1AeF @…
-
-
Mashup Score: 5Echocardiographic assessment of aortic regurgitation: a narrative review - Echo Research & Practice - 4 month(s) ago
Aortic regurgitation (AR) is the third most frequently encountered valve lesion and may be caused by abnormalities of the valve cusps or the aorta. Echocardiography is instrumental in the assessment of AR as it enables the delineation of valvular morphology, the mechanism of the lesion and the grading of severity. Severe AR has a major impact on the myocardium and carries a significant risk of morbidity and mortality if left untreated. Established and novel echocardiographic methods, such as global longitudinal strain and three-dimensional echocardiography, allow an estimation of this risk and provide invaluable information for patient management and prognosis. This narrative review summarises the epidemiology of AR, reviews current practices and recommendations with regards to the echocardiographic assessment of AR and outlines novel echocardiographic tools that may prove beneficial in patient assessment and management.
Source: echo.biomedcentral.comCategories: General Medicine News, Cardiologists1Tweet-
RT @EchoResPract: 🚨NEW ARTICLE🚨 Echocardiographic assessment of aortic regurgitation: A narrative review: https://t.co/Es0AC8Vgbl @justvi…
-
-
Mashup Score: 9
The manifestations of the athlete’s heart can create diagnostic challenges during an echocardiographic assessment. The classifications of the morphological and functional changes induced by sport participation are often beyond ‘normal limits’ making it imperative to identify any overlap between pathology and normal physiology. The phenotype of the athlete’s heart is not exclusive to one chamber or function. Therefore, in this narrative review, we consider the effects of sporting discipline and training volume on the holistic athlete’s heart, as well as demographic factors including ethnicity, body size, sex, and age.
Source: echo.biomedcentral.comCategories: General Medicine News, Hem/OncsTweet-
RT @Serginho1409: Review The athlete’s heart: insights from echocardiography https://t.co/YCbxvQ8Ohx #echofirst #CardioEd #cardiotuiter #…
-
-
Mashup Score: 10Contrast echocardiography: a practical guideline from the British Society of Echocardiography - Echo Research & Practice - 6 month(s) ago
Ultrasound contrast agents (UCAs) have a well-established role in clinical cardiology. Contrast echocardiography has evolved into a routine technique through the establishment of contrast protocols, an excellent safety profile, and clinical guidelines which highlight the incremental prognostic utility of contrast enhanced echocardiography. This document aims to provide practical guidance on the safe and effective use of contrast; reviews the role of individual staff groups; and training requirements to facilitate its routine use in the echocardiography laboratory.
Source: echo.biomedcentral.comCategories: General Medicine News, Cardiologists1Tweet-
RT @EchoResPract: 🚨NEW ARTICLE🚨 Contrast echocardiography: A practical guideline from @BSEcho: https://t.co/r10wKMPlJT @HampsonReinette @…
-
-
Mashup Score: 10Contrast echocardiography: a practical guideline from the British Society of Echocardiography - Echo Research & Practice - 6 month(s) ago
Ultrasound contrast agents (UCAs) have a well-established role in clinical cardiology. Contrast echocardiography has evolved into a routine technique through the establishment of contrast protocols, an excellent safety profile, and clinical guidelines which highlight the incremental prognostic utility of contrast enhanced echocardiography. This document aims to provide practical guidance on the safe and effective use of contrast; reviews the role of individual staff groups; and training requirements to facilitate its routine use in the echocardiography laboratory.
Source: echo.biomedcentral.comCategories: General Medicine News, Cardiologists1Tweet-
RT @EchoResPract: 🚨NEW ARTICLE🚨 Contrast echocardiography: A practical guideline from @BSEcho: https://t.co/r10wKMPlJT @HampsonReinette @…
-
-
Mashup Score: 0British Society of Echocardiography guideline for the transthoracic echocardiographic assessment of cardiac amyloidosis - Echo Research & Practice - 8 month(s) ago
These guidelines form an update of the BSE guideline protocol for the assessment of restrictive cardiomyopathy (Knight et al. in Echo Res Prac, 2013). Since the original recommendations were conceived in 2013, there has been an exponential rise in the diagnosis of cardiac amyloidosis fuelled by increased clinician awareness, improvements in cardiovascular imaging as well as the availability of new and effective disease modifying therapies. The initial diagnosis of cardiac amyloidosis can be challenging and is often not clear-cut on the basis of echocardiography, which for most patients presenting with heart failure symptoms remains the first-line imaging test. The role of a specialist echocardiographer will be to raise the suspicion of cardiac amyloidosis when appropriate, but the formal diagnosis of amyloid sub-type invariably requires further downstream testing. This document seeks to provide a focused review of the literature on echocardiography in cardiac amyloidosis highlighting i
Source: echo.biomedcentral.comCategories: Cardiologists, Latest HeadlinesTweet-
RT @Ed_Alania: https://t.co/v79KeZt0jH
-
🔝Evaluación ventrículo derecho en futbolistas adolescentes @EchoResPract 1/ Definición rangos de referencia. 2/ Análisis para diferenciar miocardiopatía arritmogénica. @DanXAugustine @jwillis82 @SSivalokanathan @Abbaszaidi77 et al. #CardiologiaDeportiva https://t.co/TsnOfSEnDF https://t.co/p8oGJ9XoCC